Physiologically based pharmacokinetics and cancer risk assessment.

por Andersen, M E, Krishnan, K
Publicado 1994

An approach to mechanism-based cancer risk assessment for formaldehyde.

por Conolly, R B, Andersen, M E
Publicado 1993

The use of biochemical and molecular parameters to estimate dose-response relationships at low levels of exposure.

por Andersen, M E, Barton, H A
Publicado 1998

Physiologically based pharmacokinetic analyses of simple mixtures.

por Krishnan, K, Clewell, H J, Andersen, M E
Publicado 1994

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment.

por Krewski, D, Withey, J R, Ku, L F, Andersen, M E
Publicado 1994

An interpolatory ansatz captures the physics of one-dimensional confined Fermi systems

por Andersen, M. E. S., Dehkharghani, A. S., Volosniev, A. G., Lindgren, E. J., Zinner, N. T.
Publicado 2016

Using available in vitro metabolite identification and time course kinetics for β-chloroprene and its metabolite, (1-chloroethenyl) oxirane, to include reactive oxidative metabolit...

por Campbell, J. L., Clewell, H. J., Van Landingham, C., Gentry, P. R., Andersen, M. E.
Publicado 2023

Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.

por Gearhart, J M, Jepson, G W, Clewell, H J, Andersen, M E, Conolly, R B
Publicado 1994

Quantitative mechanistically based dose-response modeling with endocrine-active compounds.

por Andersen, M E, Conolly, R B, Faustman, E M, Kavlock, R J, Portier, C J, Sheehan, D M, Wier, P J, Ziese, L
Publicado 1999

PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure.

por Thomas, R S, Yang, R S, Morgan, D G, Moorman, M P, Kermani, H R, Sloane, R A, O'Connor, R W, Adkins, B, Gargas, M L, Andersen, M E
Publicado 1996